Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus
Journal
Open Access Macedonian Journal of Medical Sciences
Date Issued
2019-05-31
Author(s)
Grivceva-Stardelova, Kalina
Joksimovic, Nenad
DOI
10.3889/oamjms.2019.459
Abstract
Chronic hepatitis C virus infection represents a more frequent cause of liver cirrhosis and hepatocellular carcinoma. Statins, inhibit HCV replication in vitro, enhance the antiviral effect of the already known antiviral drugs and reduce their resistance.
